Browse EX-10 agreements

LOAN TERM SHEET

This Loan Term Sheet dated 5/29/2026 (the “Loan Effective Date”) between FalconX Charlie, Inc (“Lender”) and Avalanche Treasury Company LLC (“Borrower”) and incorporates all of the terms of the Master Lender Agreement between Lender and Borrower on March 20, 2026 as per the following specific terms:

Lender:	FalconX Charlie, Inc.
Borrower:	Avalanche Treasury Company LLC
Loaned Assets:	$25,000,000
Loan Fee:	7.00% p.a.
Loan Type:	Open Loan
Collateral:	AVAX
Initial Collateral Ratio:	200%
Margin Call Limit:	180%
Liquidation Threshold/Default Limit:	160%
Refund Limit:	230%
Additional Terms:

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. “[***]” INDICATES THAT INFORMATION HAS BEEN REDACTED.

MASTER LENDER AGREEMENT

This Master Lender Agreement (“Agreement”) is made on this March 20, 2026 (“Effective Date”) by and between FalconX Charlie, Inc, (“Lender”), a corporation organized and existing under the laws of Delaware with its principal place of business at 1850 Gateway Drive, 6th floor San Mateo CA, 94404 US and Avalanche Treasury Company LLC (“Borrower”) a corporation residing and existing under the laws of Wilmington with its principal place of business at 413 W 14th Street, Suite #4633, Floor 2, New York, NY 10014.

Lender and Borrower are each individually, a “Party,” and collectively the “Parties.”

RECITALS

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. “[***]” INDICATES THAT INFORMATION HAS BEEN REDACTED.

MASTER LENDER AGREEMENT

This Master Lender Agreement (“Agreement”) is made on this March 20, 2026 (“Effective Date”) by and between FalconX Charlie, Inc, (“Lender”), a corporation organized and existing under the laws of Delaware with its principal place of business at 1850 Gateway Drive, 6th floor San Mateo CA, 94404 US and Avalanche Treasury Company LLC (“Borrower”) a corporation residing and existing under the laws of Wilmington with its principal place of business at 413 W 14th Street, Suite #4633, Floor 2, New York, NY 10014.

Lender and Borrower are each individually, a “Party,” and collectively the “Parties.”

RECITALS

…

LOAN TERM SHEET

This Loan Term Sheet dated 5/29/2026 (the “Loan Effective Date”) between FalconX Charlie, Inc (“Lender”) and Avalanche Treasury Company LLC (“Borrower”) and incorporates all of the terms of the Master Lender Agreement between Lender and Borrower on March 20, 2026 as per the following specific terms:

Lender:	FalconX Charlie, Inc.
Borrower:	Avalanche Treasury Company LLC
Loaned Assets:	$25,000,000
Loan Fee:	7.00% p.a.
Loan Type:	Open Loan
Collateral:	AVAX
Initial Collateral Ratio:	200%
Margin Call Limit:	180%
Liquidation Threshold/Default Limit:	160%
Refund Limit:	230%
Additional Terms:

…

Name of Grantee:
Grant Date:
Number of Performance-Based Restricted Stock Units at Target Performance:
Performance Period:
Vesting Date:
Walmart Identification Number:

WALMART INC.

STOCK INCENTIVE PLAN OF 2025

GLOBAL SHARE-SETTLED PERFORMANCE-BASED RESTRICTED STOCK UNIT NOTIFICATION OF AWARD AND TERMS AND CONDITIONS OF AWARD

This Global Share-Settled Performance-Based Restricted Stock Unit Notification of Award and Terms and Conditions of Award, including any applicable supplemental terms and conditions and/or any applicable additional terms and conditions for your specific country set forth in any appendices attached hereto (jointly, the “Agreement”), contain the terms and conditions of the performance-based restricted stock units (“PRSUs”) granted to you by Walmart Inc., a Delaware corporation (“Walmart”), under the Walmart Inc. Stock Incentive Plan of 2025, as may be amended from time to time (the “Plan”).

…

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of May 14, 2026 by and among Whitehawk Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).

RECITALS

WHEREAS, the Company and the Purchasers are parties to a Securities Purchase Agreement, dated as of May 12, 2026 (the “Purchase Agreement”), pursuant to which the Purchasers are purchasing shares of capital stock and/or pre-funded warrants of the Company; and

WHEREAS, in connection with the consummation of the transactions contemplated by the Purchase Agreement, and pursuant to the terms of the Purchase Agreement, the parties desire to enter into this Agreement in order to grant certain rights to the Purchasers as set forth below.

…

Certain identified information has been excluded from the exhibit filed herewith because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Such excluded information is indicated by brackets and asterisks (“[***]”) in the filed exhibit.

Subscription Agreement

Dated 26th MAY 2026

TREASURE GLOBAL INC

(Registration No. 7908921)

(“Company” or “TGL”)

AND

THE PARTIES DESCRIBED IN SCHEDULE 1

(“the Investors”)

SUBSCRIPTION AGREEMENT

Certain identified information has been excluded from the exhibit filed herewith because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Such excluded information is indicated by brackets and asterisks (“[***]”) in the filed exhibit.

Subscription Agreement

THIS SUBSCRIPTION AGREEMENT (“Agreement”) is made on 26th May 2026

BETWEEN

…

Exhibit 10.1

AMENDMENT NO. 4 TO EMPLOYMENT AGREEMENT

This Fourth Amendment to the Employment Agreement (this “Amendment No. 4”) is made and entered into as of the 27th day of May 2026 (the “Amendment Effective Date”), by and between Safe Pro Group Inc., a Delaware corporation (the “Corporation”), and Theresa Carlise (the “Executive”).

WHEREAS, the Corporation and Executive entered into an employment agreement dated June 22, 2023 (the “Employment Agreement”); and

WHEREAS, the Corporation and Executive entered into an amendment to the employment agreement dated November 1, 2023, Amendment No. 1 (“Amendment No. 1”); and

WHEREAS, the Corporation and Executive entered into an amendment to the employment agreement dated March 27, 2024, Amendment No. 2 (“Amendment No. 2”); and

WHEREAS, the Corporation and Executive entered into an amendment to the employment agreement dated April 1, 2026, Amendment No. 3 (“Amendment No. 3”); and

…

EXECUTION VERSION

EIGHTH AMENDMENT TO RECEIVABLES PURCHASE AGREEMENT

THIS EIGHTH AMENDMENT TO RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of May 29, 2026 but effective as of June 26, 2026, is entered into among LYB RECEIVABLES LLC, a Delaware limited liability company, as seller (the “Seller”), LYONDELL CHEMICAL COMPANY, a Delaware corporation (“Lyondell Chemical”), as initial servicer (in such capacity, together with its successors and permitted assigns in such capacity, the “Servicer”), the various CONDUIT PURCHASERS, RELATED COMMITTED PURCHASERS, LC PARTICIPANTS and PURCHASER AGENTS party hereto, and MIZUHO BANK, LTD. (“Mizuho”), as issuer of Letters of Credit (in such capacity, together with its successors and assigns in such capacity, the “LC Bank”), and as Administrator (in such capacity, together with its successors and assigns in such capacity, the “Administrator”).

RECITALS

…

AMENDMENT NO. 5 TO

EDESA BIOTECH, INC.

2019 EQUITY INCENTIVE COMPENSATION PLAN

This Amendment No. 5 to the Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan (this “Amendment”) is made and entered into effective as of March 18, 2026 (the “Effective Date”), by Edesa Biotech, Inc., a British Columbia corporation (the “Company”).

RECITALS

WHEREAS, the Company previously adopted the Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan (the “Plan”);

WHEREAS, by written consent of the Company’s Board of Directors (the “Board”), dated as of the Effective Date, the Board approved an increase in the number of shares of the Company’s Common Shares reserved for issuance under the Plan by 750,000 shares; and

WHEREAS, the Board also approved elimination of the limit on the number of Common Shares that may be awarded as “Options” (as defined by the Plan) to a participant during any calendar year;

…

May 26, 2026

Tina Goldenberg

Dear Tina,

I am pleased to confirm your promotion to Vice President & Chief Accounting Officer with Avis Budget Car Rental, LLC (the “Company”), effective June 15, 2026, based at the Company’s headquarters located in Parsippany, New Jersey. In connection with your promotion, you will also serve as Chief Accounting Officer of Avis Budget Group, Inc. This offer and your employment relationship will be subject to the terms and conditions of this letter as well as the Company’s Code of Conduct and other policies, procedures, plans and agreements applicable to your role.

Your salary on an annualized basis will be $270,000 (USD) and paid on a bi-weekly basis. This position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay. Your salary is intended to compensate you for all hours worked. Your work hours may vary from week to week depending on the Company’s needs.

…

Exhibit 10.2

RESTRICTED STOCK AWARD AGREEMENT

ENVERIC BIOSCIENCES, INC.

2020 LONG-TERM INCENTIVE PLAN

1. Grant of Award. Pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the “Plan”) for Employees, Contractors, and Outside Directors of Enveric Biosciences, Inc., a Delaware corporation (the “Company”), the Company grants to

(the “Participant”)

an Award of Restricted Stock in accordance with Section 6.4 of the Plan. The number of shares of Common Stock awarded under this Restricted Stock Award Agreement (the “Agreement”) is ______________ (_______) shares (the “Awarded Shares”). The “Date of Grant” of this Award is ___________________.

…